Robert F. Kennedy Jr., the independent presidential candidate known for his controversial stance on vaccines, has selected a team of advisers to shape his vaccine policies. This group—largely composed of like-minded skeptics—is meeting for the first time, signaling a potential push to center vaccine skepticism in his campaign.

The newly appointed vaccine advisory team under U.S. Health Secretary Robert F. Kennedy Jr. has held its inaugural meeting, marking the first step in shaping the administration’s approach to immunization policies. The group’s formation signals a fresh direction—or at least a reevaluation—of how the government handles vaccine recommendations, though details on their agenda remain sparse.

Robert F. Kennedy Jr. announced that major health insurers have agreed to streamline the often-frustrating prior authorization process—a bureaucratic hurdle that frequently slows down or blocks patients from getting timely care. While details are still vague, the move suggests insurers are responding to mounting criticism about unnecessary delays in treatment.

Robert F. Kennedy Jr. has assembled a panel of experts to review the CDC's recommended vaccine schedule for children. Since this advisory group influences national vaccination policies, their findings could potentially reshape immunization practices for millions of kids—raising questions about safety, necessity, and public health priorities.

Republican Senator Bill Cassidy is raising red flags about Health Secretary Robert F. Kennedy Jr.’s newly appointed vaccine advisory panel, arguing its members lack the right expertise. Cassidy wants the committee’s meeting postponed until more qualified experts are brought on board.

During her Senate confirmation hearing, CDC nominee Susan Monarez emphasized her support for vaccines and science but carefully avoided direct answers about potential budget cuts to the agency and whether she clashed with Health Secretary RFK Jr. on key issues. Her evasive responses left some lawmakers frustrated, hinting at tensions behind the scenes.

During Susan Monarez’s Senate hearing for CDC director, the shadow of RFK Jr.’s controversial vaccine skepticism hung in the air. While Monarez wasn’t directly grilled on the topic, the unspoken tension highlighted how divisive vaccine discourse remains in public health leadership.

RFK Jr. claims the U.S. is halting funding for Gavi, a major global vaccine organization, citing concerns over how the group addresses vaccine safety in its campaigns. The Health and Human Services secretary suggests funding will only resume if Gavi incorporates what they call "the science of vaccine safety" into its work.

Editor’s Note: This could signal a significant shift in U.S. global health policy, especially around vaccine distribution. If funding is pulled, it might weaken efforts to combat preventable diseases worldwide—raising questions about the balance between safety concerns and public health priorities. It’s also likely to fuel ongoing debates about vaccine skepticism and government oversight.

A vaccine advisory committee handpicked by RFK Jr. is gearing up to take a hard look at the standard childhood immunization schedule—including vaccines that have been used safely for years. Critics worry this could open the door to rolling back proven protections, while supporters see it as overdue scrutiny. Either way, it’s a big deal because these recommendations shape what shots kids get nationwide.